Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260728 · ClinicalTrials.gov registry record · Phase 2
The Boston Scientific ACCESS Trial
A Phase 2 study, sponsored by Maquet Cardiovascular.
- Terminated
- Registry status
- Phase 2
- Development phase
- 149
- Enrollment target
NCT00260728 is a Phase 2 study that was terminated before completion, run by Maquet Cardiovascular. The registered enrollment target is 149 participants.
The verdict
NCT00260728, a Phase 2 study, was terminated before completion, sponsored by Maquet Cardiovascular.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 149 participants
- Enrollment target
Study Summary
The Boston Scientific ACCESS trial seeks to study the safety and to evaluate the success of the Fusion™ Vascular Access Graft for patients in need of early vascular access for hemodialysis.
Interventions
- DEVICE vascular access graft implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00260728
The ClinicalTrials.gov registry entry for NCT00260728 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Maquet Cardiovascular, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vascular access graft implantation is the first listed.
NCT00260728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00260728 about?
NCT00260728 is a clinical study titled "The Boston Scientific ACCESS Trial". The Boston Scientific ACCESS trial seeks to study the safety and to evaluate the success of the Fusion™ Vascular Access Graft for patients in need of early vascular access for hemodialysis.
What is the current status of trial NCT00260728?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 149 participants. The study started on 2005-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00260728?
The interventions under investigation include: vascular access graft implantation (DEVICE).
Who is sponsoring clinical trial NCT00260728?
This trial is sponsored by Maquet Cardiovascular, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.